Archive for the ‘Lyme’ Category

Seroprevalence of Borrelia, Anaplasma, Bartonella, Toxoplasma, Mycoplasma, Yersinia, and Chlamydia in Human Population From Eastern Poland

https://www.mdpi.com/2076-0817/14/1/96

Seroprevalence of BorreliaAnaplasmaBartonellaToxoplasmaMycoplasmaYersinia, and Chlamydia in Human Population from Eastern Poland

by Angelina Wójcik-Fatla 1, Anna Sawczyn-Domańska 1,*, Anna Kloc 1,Joanna Krzowska-Firych 2 and Jacek Sroka 1,3

*Author to whom correspondence should be addressed.

Pathogens 202514(1), 96; https://doi.org/10.3390/pathogens14010096

Submission received: 3 December 2024 / Revised: 15 January 2025 / Accepted: 16 January 2025 / Published: 18 January 2025

(This article belongs to the Special Issue Exploring the Biodiversity of Parasites in Humans, Wild and Domestic Animals)

Abstract

The epidemiological situation related to infectious diseases is influenced by many factors. To monitor actual trends in selected zoonoses, a total of 473 serum samples from farmers, forestry workers, and veterinarians were collected for serological examination. Anti-Borrelia burgdorferi sensu lato (s.l.) antibodies were tested with ELISA and Western blot (WB) tests; the detection of anti-Toxoplasma gondii antibodies was performed using an enzyme linked fluorescence assay (ELFA). Antibodies to bartonellosis, anaplasmosis, and chlamydiosis were determined by indirect immunofluorescent test (IFA), whereas antibodies to yersiniosis and mycoplasmosis were confirmed in the ELISA test.

Positive or borderline results of antibodies against B. burgdorferi s.l. in the ELISA test were detected in 33.8% of the study population. The borderline or positive ELISA test results for at least one antibody class were confirmed by WB in 58.7% of cases. The IgG antibodies against Anaplasma phagocytophilumToxoplasma gondii, and Mycoplasma pneumoniae were detected in 9.6%, 51.7%, and 63.6% of samples, respectively. Antibodies against Yersinia spp., Bartonella henselae, and Chlamydia pneumoniae were found to vary between 43 and 47%.

Lyme, Morgellons, and Patients Still Fighting to Be Heard: Dr. Ginger Savely

https://www.morgellonssurvey.org/ginger-savely-take-charge-of-your-health-lyme-morgellons/

Dr. Ginger Savely Joins Take Charge of Your Health to Discuss Lyme Disease, Morgellons, and the Patients Still Fighting to Be Heard

May 30, 2026 by Jeremy Murphree

Dr. Ginger Savely recently joined Take Charge of Your Health with Corinne and Carol for an important conversation about Lyme disease, chronic illness, and the misunderstood patients who continue searching for answers.

For the Morgellons community, this interview matters.

Dr. Savely has been one of the most visible and consistent clinicians willing to take Morgellons patients seriously. Long before the condition had any meaningful public recognition, she was listening to patients, examining lesions, documenting fibers, publishing clinical observations, and challenging the assumption that every patient reporting fibers, crawling sensations, or non-healing skin lesions must be suffering from a psychiatric disorder.

As a Morgellons patient advocate, I believe this type of public conversation is essential. Patients do not need more ridicule. They need careful evaluation, better science, better diagnostics, and clinicians willing to look before they dismiss.

(See link above for entire article)

Approximately 1 Hour

For more:

HHS Secretary on Lyme Disease

HHS Secretary Kennedy on Lyme Disease

May 29, 2026

Kennedy recently spoke in Concord, New Hampshire

HHS Sounds Alarm as Lyme Disease Cases Surge

_____________________

**Comment**

Hope stems from the fact HHS announced a new public private collaboration with ILADS – the only physician organization that recognizes Lyme can be a chronic, persistent infection. This group also trains doctors and connects patients with experienced providers.

For more on ILADS: https://www.ilads.org/

We need to be asking doctors to become educated on tickborne illness: https://iladef.org/physician-training-program/

HHS Deputy Assistant Secretary Dr. Stephanie Haridopolos never answered the question in the second video about ticks being dropped all over farms as many on social media are reporting. Crickets……

The newscaster also blamed warmer winters as one reason for tick and disease proliferation – but this has been proven false by independent research: https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/ Scott found warmer winters are lethal to black legged ticks.

Just to be clear, our government has a long sordid history of experimenting on ticks, stuffing them with numerous pathogens, and then dispersing them out of airplanes:

The Lyme Disease File: What Was Left Unanswered

March 25, 2026

In the mid-1970s, a cluster of unexplained illnesses appeared in a small town in Connecticut. It would later be called Lyme disease. But how was the investigation handled? What questions were closed? And what records still remain unseen? This 32-minute investigative documentary examines the early history of Lyme disease, the institutional response, and the broader issue of transparency in public health decision-making.

This is not about assigning blame. This is not about promoting a predetermined theory.

It is about one principle: If federal records exist regarding Lyme’s early history, the public deserves to see them. The MAHA movement has emphasized a simple idea: transparency strengthens trust. That applies here. If you believe transparency matters — watch the full investigation, share it, and use #ReleaseTheLymeFiles

Conspiracies don’t begin with imagination. They begin when transparency ends.

CHAPTERS ━━━━━━━━━━━━━━━━━━━━━━━━━━

0:00 The weapon that crawled, bit, and disappeared

1:23 Old Lyme, Connecticut — where it started

2:43 One mother’s notes changed everything

4:54 Plum Island — the government lab 8 miles away

7:03 The US military used insects as disease carriers — it’s documented

9:22 The timeline that’s hard to ignore

10:13 Why Borrelia doesn’t behave like a normal infection

13:53 Records sealed, witnesses go silent

17:06 Boxes lost at sea, dead birds, and Lab 257

20:01 What if we’re wrong — challenging the theory

23:29 Patients today — still dismissed, still without answers

25:34 The 2025 federal Lyme roundtable

27:21 Operation Paperclip and Erich Traub

29:07 What we know, what we don’t, and what was never told

For more:

New Lyme Vaccine: How Much BS Can We Tolerate?

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/34624473

NEW LYME VACCINE: How much vaccine BS (safe and effective) can we tolerate??

Carl Tuttle Hudson, NH, United States

May 17, 2026

—– Forwarded Message —–
From: CARL TUTTLE <runagain@comcast.net>
To: thart15@jh.edu <thart15@jh.edu>
Cc: kremington@ktvn.com <kremington@ktvn.com>; producers@ktvn.com <producers@ktvn.com>
Sent: Sunday, May 17, 2026 at 09:16:59 AM EDT
Subject: Health Watch: Lyme disease vaccine

KTVN 2 News Nevada

Kristen Remington Anchor/Reporter

Health Watch: Lyme disease vaccine

Quote:

“There used to be a Lyme disease vaccine called LYMErix in the late 90’s and early 2000’s. This was eventually pulled off the market due to low sales.” -Thomas M. Hart, PhD

Thomas M. Hart, PhD

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street, E5638

Baltimore Maryland 21205

Dr. Hart,

“Low sales” of the LYMErix vaccine is not the entire truth and has been regurgitated across mainstream media. 

The vaccine known as LYMErix was supposed to expose the immune system to the outer surface protein A (OspA) of the spirochete responsible for causing Lyme disease but for some patients, it caused the same crippling effects of the disease itself as reported in the class action lawsuit:

https://www.dropbox.com/s/sodqs3pdeeesktf/Sheller%20Lymerix.pdf?dl=0

Excerpt from the lawsuit:

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:

https://www.dropbox.com/scl/fi/811ar7u22g1x7vrgiwjhx/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf?rlkey=ot1sl13exzgm2bv7ldfe7ks53&dl=0

A chronic relapsing seronegative disease does not fit the vaccine model so chronic Lyme which is completely devastating to the patient is not recognized and there is no treatment. The disabled Lyme patient is left to fend for himself because treating this class of patient became too expensive as outlined in the racketeering lawsuit. There is a growing community of horribly disabled patients whose disability has gone unrecognized for three decades.

Here’s yet another victim:

Nicole Malachowski: Unfit for Duty from Debilitating Tick-Borne Disease

http://cdmrp.army.mil/cwg/stories/2018/nicole_malachowski_profile

“Her medical retirement, however, was premature. At only 43 years old, she was deemed unfit for duty due to neurological damage from tick-borne illness.”

The latest vaccine from French drug manufacturer Valneva is another OspA vaccine similar to LYMErix so the possibility exists that the class of patient who experienced the debilitating effects of LYMErix could end up with the same results. There was no attempt to uncover why LYMErix disabled the patient as described in the class action. Until we fully understand how Lyme disease disables its victim aren’t we playing Russian roulette with people’s health?

Respectfully Submitted,

Carl Tuttle

Independent Researcher

Hudson, NH

Suppressing evidence of persistent infection after antibiotic treatment for Lyme disease is not collaboration, it is collusion:

Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 references)

https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

For more: